Literature DB >> 19235656

Liver transplantation: the current situation.

Rene Adam1, Emir Hoti.   

Abstract

Over the years, an improving liver transplant (LT) survival rate (1- and 5-year survival of 83% and 75%, respectively) has been instrumental in establishing transplant surgery as a durable therapy for all forms of end-stage liver disease and for some malignant conditions. The success of such treatment has resulted in a progressively increasing demand for liver transplantation. However, at the same time the availability of donor organs has diminished, resulting in the number of potential recipients for liver transplantation exceeding organ supply. Several strategies have been explored with the aim to increase access to liver transplantation, including: obtaining organs from non-heart-beating donors and live donors, and splitting and using livers from expanded donor criteria. This article discusses the utility of the mentioned techniques along with other strategies (e.g., Model for End-Stage Liver Disease [MELD] score), as well as the evolution of indications, contraindications, and postoperative care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235656     DOI: 10.1055/s-0029-1192052

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  28 in total

1.  Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.

Authors:  Harald Schrem; Melanie Reichert; Benedikt Reichert; Thomas Becker; Frank Lehner; Moritz Kleine; Hüseyin Bektas; Kai Johanning; Christian P Strassburg; Jürgen Klempnauer
Journal:  Langenbecks Arch Surg       Date:  2011-12-06       Impact factor: 3.445

Review 2.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  Acute renal failure in liver transplant patients: Indian study.

Authors:  Pradeep Naik; B Premsagar; M Mallikarjuna
Journal:  Indian J Clin Biochem       Date:  2013-11-23

4.  Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial.

Authors:  Ivan Kristo; Julia Wilflingseder; Alexander Kainz; Julian Marschalek; Thomas Wekerle; Ferdinand Mühlbacher; Rainer Oberbauer; Martin Bodingbauer
Journal:  Transpl Int       Date:  2011-06-14       Impact factor: 3.782

5.  T-tube or no T-tube for bile duct anastomosis in orthotopic liver transplantation.

Authors:  Ajith K Sankarankutty; Enio D Mente; Nathalia M Cardoso; Orlando Castro-E-Silva
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

6.  Nutritional status and liver transplantation.

Authors:  Manuela Merli; Michela Giusto; Valerio Giannelli; Cristina Lucidi; Oliviero Riggio
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

7.  CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model.

Authors:  Zhen-Yu Xiao; Babak Banan; Jianluo Jia; Pamela T Manning; Ronald R Hiebsch; Muthukumar Gunasekaran; Gundumi A Upadhya; William A Frazier; Thalachallour Mohanakumar; Yiing Lin; William C Chapman
Journal:  Liver Transpl       Date:  2015-01-29       Impact factor: 5.799

8.  Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.

Authors:  Vincent E de Meijer; Deanna Y Sverdlov; Yury Popov; Hau D Le; Jonathan A Meisel; Vânia Nosé; Detlef Schuppan; Mark Puder
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

9.  Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation.

Authors:  Xin-Hua Zhu; Ya-Fu Wu; Yu-Dong Qiu; Chun-Ping Jiang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1.

Authors:  Kwang Hwa Jung; Ryan L McCarthy; Chong Zhou; Nadima Uprety; Michelle Craig Barton; Laura Beretta
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.